Creator: Help Dementia Editorial Team
Published: 2026-04-23T07:04:32

Reviewed by the Help Dementia Editorial Team — our editors review every article for accuracy against guidance from the National Institute on Aging, the Alzheimer’s Association, and peer-reviewed sources.

Popular supplement sits at the center of this dementia and brain health question.

Recent research has identified several supplements that show potential in protecting against Alzheimer’s disease and cognitive decline, with some compounds demonstrating the ability to reduce amyloid plaques and preserve memory function. Among these, HMB (beta-hydroxy beta-methylbutyrate)—a muscle-building supplement available over-the-counter in sports stores—has emerged as a particularly promising candidate after researchers at Rush University discovered it may help protect memory by reducing the amyloid plaques associated with Alzheimer’s pathology. Other compounds like lithium orotate, arginine, and riboflavin (vitamin B2) have also shown protective effects in research studies, offering hope to millions of people seeking ways to protect their cognitive health. However, it’s crucial to understand that while these findings are encouraging, no supplement has been proven to prevent, treat, or cure Alzheimer’s disease.

The research represents an important first step, but most findings come from laboratory studies or animal models, with limited human clinical trial data. This distinction matters significantly when considering whether to add these supplements to a dementia prevention strategy. The landscape of supplement research for cognitive health has shifted dramatically in recent years. Where once we had limited options beyond general vitamins, we now have specific compounds with identifiable mechanisms of action targeting the biological hallmarks of Alzheimer’s disease. This article examines what the research actually shows about these supplements, what remains unknown, and how to think strategically about incorporating them into a brain health routine.

Which Supplements Now Show Promise in Alzheimer’s Prevention?
How Do These Supplements Work Against Alzheimer’s Disease?
What Does Current Research Evidence Actually Tell Us?
How Should You Approach Adding These Supplements to Your Brain Health Routine?
What Are the Limitations and Safety Concerns?
Which Supplements Showed Promise but May Not Deliver?
The Future of Supplement Research in Alzheimer’s Prevention
Conclusion

Which Supplements Now Show Promise in Alzheimer’s Prevention?

Multiple supplements have recently demonstrated protective effects against Alzheimer’s pathology in research settings. HMB, traditionally used by athletes to build muscle mass, showed unexpected benefits when Rush University researchers examined its effects on amyloid plaques—the toxic protein accumulations that damage neurons in Alzheimer’s disease. The supplement appears to work through mechanisms that reduce plaque formation while improving memory function, and it comes with the advantage of being affordable, widely available, and showing no known side effects even with long-term use. Lithium orotate represents another intriguing option, though one that requires more caution.

Research published in Nature demonstrated that this lithium compound could prevent and reverse Alzheimer’s pathology and memory loss in mouse models, suggesting it may stabilize and even repair damage caused by the disease. Unlike lithium carbonate (used in psychiatric treatment at higher doses), lithium orotate is available as a dietary supplement in lower doses, though this lower-dose approach remains unproven in human clinical trials. Arginine, an amino acid available as an inexpensive supplement, has shown the ability to lower amyloid-beta aggregation and reduce inflammation in animal models while improving behavioral outcomes. Finally, riboflavin (vitamin B2) offers a particularly compelling case study: older adults who consumed the highest amounts of this common B vitamin had a 49% lower risk of developing disabling dementia compared to those with the lowest intake. This suggests that even achieving adequate levels of an inexpensive, well-known nutrient could meaningfully reduce cognitive decline risk—making it perhaps the most accessible preventive approach of all.

Which Supplements Now Show Promise in Alzheimer's Prevention?

How Do These Supplements Work Against Alzheimer’s Disease?

Understanding the mechanisms of action helps clarify why these different supplements all show promise despite coming from different chemical families. HMB appears to work by reducing amyloid plaque accumulation—essentially slowing the buildup of the toxic protein that triggers neuroinflammation and neuronal death. This reduction in plaques directly addresses one of the fundamental pathological processes of Alzheimer’s disease, which is why the Rush University findings generated significant interest among neuroscientists. Lithium orotate operates through different mechanisms, including effects on tau tangles (another pathological hallmark of Alzheimer’s) and inflammation regulation.

The Nature study showed not just prevention of disease development but actual reversal of existing pathology—a remarkable finding that distinguishes it from compounds that merely slow decline. However, this more powerful activity profile also suggests greater potential for side effects or interactions, a significant limitation for any supplement being considered for long-term use. Arginine lowers amyloid plaques through anti-inflammatory mechanisms, reducing the brain inflammation that drives neurodegeneration. Riboflavin appears to work through metabolic pathways that protect mitochondrial function—the energy-producing centers of neurons—making it particularly relevant since mitochondrial dysfunction is an early feature of cognitive decline. These different mechanisms suggest that a multi-supplement approach targeting different pathways could theoretically be more effective than relying on a single compound, though this remains an untested hypothesis.

What Does Current Research Evidence Actually Tell Us?

The critical distinction in supplement research is the difference between promising laboratory findings and proven human benefit. The HMB research comes from laboratory studies and animal models—not human clinical trials. Similarly, the lithium orotate findings that showed reversal of Alzheimer’s pathology were generated in mice, not people. This gap between animal models and human outcomes is enormous in neuroscience; drugs that work perfectly in mice frequently fail in human trials or show much more modest effects. The riboflavin evidence offers a somewhat different picture.

Rather than controlled studies of supplementation, the findings come from observational research examining dietary intake in populations. While this shows an association between higher B2 consumption and lower dementia risk, it doesn’t prove that taking a supplement will reduce your risk. People who consume more riboflavin-rich foods may also engage in other healthy behaviors that protect cognition—better diet overall, more physical activity, stronger social engagement—making it impossible to isolate riboflavin’s specific contribution. The arginine research, while showing measurable effects on amyloid levels in animal models, also lacks human clinical trial data demonstrating cognitive protection. This means we have mechanisms, we have laboratory evidence, and we have suggestive associations in human populations—but we do not yet have proof that these supplements prevent, treat, or cure cognitive decline in people. This is not a criticism of the research; it’s an acknowledgment of where the science currently stands.

What Does Current Research Evidence Actually Tell Us?

How Should You Approach Adding These Supplements to Your Brain Health Routine?

If you’re considering supplementation based on this emerging research, the practical first step is consulting with your healthcare provider, particularly if you take other medications or have existing health conditions. This matters because supplements can interact with medications—for example, lithium compounds can interact with medications affecting kidney function—and some health conditions may create specific concerns. For someone interested in pursuing supplement-based cognitive protection, riboflavin (vitamin B2) presents the lowest barrier to entry: it’s inexpensive, widely available, has an excellent safety record, and the research connection is relatively straightforward. Ensuring adequate B-vitamin intake through either supplements or dietary sources (eggs, almonds, mushrooms, salmon) involves minimal risk.

HMB, widely available in sports nutrition stores, offers another relatively accessible option, though you would want to verify product quality and purity. The relative safety profile and affordability of HMB make it worth discussing with your healthcare provider if cognitive protection is a priority. Starting with these lower-risk options makes sense before considering lithium orotate, which has a more complex pharmacology and greater potential for interactions. If you do consider lithium orotate, it requires medical supervision and baseline testing of kidney and thyroid function. The typical approach would be starting with one supplement, maintaining it for a reasonable period (several months to a year), and then assessing whether to add additional compounds based on further research developments and your individual response.

What Are the Limitations and Safety Concerns?

Despite generally favorable safety profiles, each of these supplements carries specific considerations that shouldn’t be minimized. HMB is well-tolerated in most people, but long-term studies in older adults specifically are limited. Because it’s a metabolite of the amino acid leucine, people with severe kidney disease should approach it cautiously. Arginine supplements can interact with medications like nitroglycerin and can affect blood pressure, creating concerns for people on cardiovascular medications. Lithium orotate, while used at lower doses than lithium carbonate, still presents genuine risks.

Lithium has a narrow therapeutic window—the difference between an effective dose and a toxic dose is not large—and requires regular blood testing to ensure safety. It can affect kidney function and thyroid health, meaning anyone considering it needs baseline testing and periodic monitoring. The excitement about the Nature study findings must be tempered by the reality that all those results came from mice, and human trials might reveal unexpected safety issues that animal models missed. A deeper limitation affects all these supplements: most research has been conducted in younger animal models or controlled laboratory settings, not in older adults with multiple health conditions. The dementia prevention strategies that matter most are the ones that work in real-world conditions for real-world populations. Until we have human clinical trials demonstrating cognitive benefits, we’re extrapolating from suggestive laboratory evidence rather than basing recommendations on proven outcomes.

What Are the Limitations and Safety Concerns?

Which Supplements Showed Promise but May Not Deliver?

Omega-3 supplements provide an important cautionary tale in this context. Widely promoted for cognitive health and often recommended for dementia prevention, recent research has revealed a far more complex picture than the earlier marketing suggested. A comprehensive review of omega-3 supplementation showed that supplementation alone produced no significant cognitive benefit in studies of older adults. More concerning, some research suggests omega-3 supplements may be associated with accelerated cognitive decline in certain populations, though the mechanisms remain unclear.

This represents a significant shift from earlier thinking about omega-3s and brain health. The lesson is particularly relevant to supplement selection: popular recommendations, marketing promises, and theoretical mechanisms don’t always translate to human benefit. The enthusiasm for omega-3s came from reasonable mechanistic thinking—omega-3 fatty acids are important for brain health, and supplementing with them should theoretically help. Yet the real-world evidence simply didn’t support this logic. It’s a reminder to distinguish between “this compound is theoretically important for brain health” and “this supplement has been proven to improve cognitive outcomes.”.

The Future of Supplement Research in Alzheimer’s Prevention

The research landscape is shifting toward better human studies that will answer many current questions. Multiple clinical trials are now underway examining HMB, lithium, and other compounds in older adults with cognitive concerns. The next three to five years should provide meaningful data on whether these laboratory findings translate to real cognitive benefits in real people. This timeline matters if you’re considering supplements—being aware that better evidence is coming can inform whether to start now or wait for more definitive answers.

The broader trend in dementia research is moving toward combination approaches rather than single-compound solutions. Just as cancer treatment often uses multiple drugs targeting different pathways, future cognitive protection strategies may involve several supplements or drugs working together. However, this multiplies the complexity and the potential for interactions, underscoring why medical guidance matters increasingly as approaches become more sophisticated. The exciting potential of supplements to protect cognition should be balanced against the reality that we’re still in relatively early stages of understanding which combinations work, at what doses, for which populations, and over what timeframes.

Conclusion

Recent research has genuinely identified several supplements with plausible mechanisms for protecting against Alzheimer’s disease and cognitive decline. HMB, lithium orotate, arginine, and adequate riboflavin intake all show encouraging laboratory and preliminary human findings.

However, the critical distinction between promising research and proven prevention remains crucial: we don’t yet have clinical evidence that these supplements actually prevent, treat, or cure Alzheimer’s disease in people. If you’re interested in exploring supplement-based cognitive protection, start by discussing options with your healthcare provider, consider beginning with lower-risk compounds like riboflavin or HMB, and stay informed as clinical trial results emerge over the coming years. The intersection of emerging research and individual decision-making requires both optimism about what’s possible and honesty about what we still don’t know.